Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Novel therapies for children with severe asthma
Top Ten Searches
hla beta 2 probiotics hypo allergenic scid urticaria aeroallergens asthma angioedema hivYour Article Summary
See Latest ArticlesComparison of olopatadine 0.6% nasal spray versus fluticasone propionate 50 micro g in the treatment of seasonal allergic rhinitis
Allergy and Asthma Proceedings, 06/29/09
Kaliner MA et al. - No significant between-treatment differences were determined for the average 2-week percent changes from baseline for congestion, runny nose, sneezing, itchy nose, and ocular symptoms, although olopatadine had a faster onset of action for reducing all symptoms. Both treatments were safe and well tolerated. Olopatadine and fluticasone nasal sprays both reduced nasal and ocular SAR symptoms with no significant between-treatment differences except for a faster and greater onset of action with olopatadine.
Today in Allergy/Anaphylaxis...keeping you current
Receive free subspecialty "5-minute updates" via email
Allergic rhinitis with negative skin tests: Does it exist
Allergy and Asthma Proceedings, 10/13/09
Objective assessments of allergic and nonallergic rhinitis in young children
Allergy, 09/21/09
Role of adenoids and adenoiditis in children with allergy and otitis media
Current Allergy and Asthma Reports, 10/22/09
Today in Clinical Pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
Novel Therapies for Pemphigus Vulgaris: An Overview
Drugs & Aging, 09/21/09
Zinc: role in immunity, oxidative stress and chronic inflammation
Current Opinion in Clinical Nutrition & Metabolic Care, 10/21/09
Anti-Inflammatory Drugs in Psychiatry
Inflammation & Allergy - Drug Targets, 10/09/09
Sponsor
Article Search
Sponsor